207_Combined course Presentations
Hybrid study: SBRT with concurrent chemoradiation
Treatment planning and delivery
2 isocentres and 2 dual VMAT arcs
Compensation for indirect lymph node (LN) dose to primary tumour (PT): the biological equivalent of the minimal dose (D99) to the PT PTV from LN irradiation was subtracted from the biological prescribed dose to the PTV.
Chemotherapy consisted of daily low dose Cisplatinum 6 mg/m 2
PT: 3 x 18 Gy (purple) LN: 24 x 2.42 Gy (pink)
Courtesy of J. Belderbos
Made with FlippingBook